GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) » Definitions » Price-to-Owner-Earnings

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Price-to-Owner-Earnings : (As of Apr. 30, 2024)


View and export this data going back to 2002. Start your Free Trial

What is Gulf Pharmaceutical Industries PSC Price-to-Owner-Earnings?

As of today (2024-04-30), Gulf Pharmaceutical Industries PSC's share price is د.إ0.941. Gulf Pharmaceutical Industries PSC does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Gulf Pharmaceutical Industries PSC was 238.75. The lowest was 15.57. And the median was 29.96.


ADX:JULPHAR's Price-to-Owner-Earnings is not ranked *
in the Drug Manufacturers industry.
Industry Median: 28.39
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-04-30), Gulf Pharmaceutical Industries PSC's share price is د.إ0.941. Gulf Pharmaceutical Industries PSC's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was د.إ-0.09. Therefore, Gulf Pharmaceutical Industries PSC's PE Ratio for today is At Loss.

As of today (2024-04-30), Gulf Pharmaceutical Industries PSC's share price is د.إ0.941. Gulf Pharmaceutical Industries PSC's EPS without NRI for the trailing twelve months (TTM) ended in was د.إ-0.09. Therefore, Gulf Pharmaceutical Industries PSC's PE Ratio without NRI for today is At Loss.

During the past 13 years, Gulf Pharmaceutical Industries PSC's highest PE Ratio without NRI was 473.33. The lowest was 0.00. And the median was 13.78.


Gulf Pharmaceutical Industries PSC Price-to-Owner-Earnings Historical Data

The historical data trend for Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gulf Pharmaceutical Industries PSC Price-to-Owner-Earnings Chart

Gulf Pharmaceutical Industries PSC Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 25.92 - -

Gulf Pharmaceutical Industries PSC Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings falls into.



Gulf Pharmaceutical Industries PSC Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.941/-0.07
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Gulf Pharmaceutical Industries PSC  (ADX:JULPHAR) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Gulf Pharmaceutical Industries PSC Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Gulf Pharmaceutical Industries PSC's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Business Description

Traded in Other Exchanges
N/A
Address
Airport Road, P.O. Box 997, Digdaga, Ras Al Khaimah, ARE
Gulf Pharmaceutical Industries PSC is a generic pharmaceutical manufacturer in the Middle East and North Africa. The company manufactures and sells pharmaceuticals and medical compounds, including cosmetics compounds, and drugs. It operates in four segments: Manufacturing, Planet, Investments, and others. It maintains a diverse product portfolio that targets various therapeutic segments including Gastrointestinal Tract (GIT), Respiratory, Pain Management, Wounds & Scars, Anti-infectives, Anemia, Gynecology, Dermatology, Erectile Dysfunction, and Cardiology. The geographical segments are UAE, Other GCC countries, and Other countries.

Gulf Pharmaceutical Industries PSC (ADX:JULPHAR) Headlines

No Headlines